Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Publication year range
1.
Rev. ORL (Salamanca) ; 14(2)20-06-2023. graf, tab
Article in Spanish | IBECS | ID: ibc-221997

ABSTRACT

Introducción y objetivo: El síndrome de boca ardiente (SBA) es una afección crónica, que cursa con quemazón o dolor de la mucosa bucal, afectando predominantemente a mujeres de edad media. Puede aparecer como cuadro primario o bien de forma secundaria. La fisiopatología de esta entidad es bastante desconocida. Existe un amplio abanico terapéutico, pero por lo general precisa de un abordaje multidisciplinar. Nuestra intención es realizar una puesta al día de la enfermedad para poder hacerla frente en la consulta de otorrinolaringología. Método: Revisión bibliográfica de la literatura. Fecha de publicación limitada de 2012 a 2022. Resultados: El SBA presenta una etiopatogenia de carácter multifactorial. Para su diagnóstico es necesario realizar una exhaustiva anamnesis y exploración. Se diferencian 3 tipos distintos de SBA, siendo el tipo II el más frecuente y el más refractario a la terapia. El adecuado tratamiento se fundamenta en un correcto diagnóstico y debe ser multidisciplinar. Discusión: Es importante resaltar que es una entidad benigna. Los tratamientos son variados y no hay ninguno que destaque sobre el resto, lo que dificulta el manejo de estos pacientes. Aunque la bibliografía sobre este síndrome es abundante, no se han producido en los últimos años, importantes innovaciones en cuanto a la etiología y tratamiento. Conclusiones: La anamnesis y los estudios de laboratorio son fundamentales para descartar casusas secundarias de la enfermedad. La terapia es diversa y debe incluir derivación a salud mental como parte del manejo multidisciplinar. (AU)


Introduction and objective: Burning mouth syndrome (BMS) is a chronic condition that causes burning or pain of the oral mucosa, predominantly affecting middle-aged women. It can appear as a primary box or secondary. The pathophysiology of this entity is quite unknown. There is a varied therapeutic range, but it generally requires a multidisciplinary approach. Our intention is to update the disease in order to deal with it in the otorhinolaryngology consultation. Method: Bibliographic review of the literature. Limited release date from 2012 to 2022. Results: BMS has a multifactorial etiopathogenesis. For its diagnosis it is necessary to carry out an exhaustive anamnesis and examination. There are 3 different types of BMS, type II being the most frequent and the most refractory to therapy. Adequate treatment is based on a correct diagnosis and must be multidisciplinary. Discussion: It is important to emphasize that it is a benign entity. The treatments are varied and there is none that stands out above the rest, which makes it difficult to manage these patients. Although the bibliography on this syndrome is abundant, important innovations in terms of etiology and treatment have not been produced in recent years. Conclusions: Anamnesis and laboratory studies are essential to rule out secondary causes of the disease. Therapy is varied and should include referral to mental health as part of multidisciplinary management. (AU)


Subject(s)
Humans , Burning Mouth Syndrome , Glossalgia
2.
Rev. otorrinolaringol. cir. cabeza cuello ; 82(1): 86-94, mar. 2022. tab, ilus
Article in Spanish | LILACS | ID: biblio-1389836

ABSTRACT

Resumen El síndrome de la boca ardiente (SBA) es una condición de dolor crónico en la cavidad oral, que se presenta mayoritariamente en mujeres de edad media. Diversas causas locales y sistémicas pueden producirlo en forma secundaria, o bien, puede representar un cuadro primario, sin etiología específica identificable. Su etiopatogenia y evolución clínica es poco comprendida. Las opciones terapéuticas son variadas y en general es necesario un tratamiento multidisciplinario. A continuación, se presenta una revisión de la literatura respecto a esta patología para difusión en nuestro medio.


Abstract Burning mouth syndrome (BMS) is a chronic pain condition of the oral cavity, which occurs more frequently in middle-aged women. It can be secondary to different local and systemic causes, or represent a primary condition, with no specific identifiable etiology. Its etiopathogenesis and clinical evolution are poorly understood. Therapeutic options are multiple and a multidisciplinary treatment is necessary. We present a review of the literature regarding BMS, to provide information relevant to our area of expertise.


Subject(s)
Humans , Burning Mouth Syndrome/diagnosis , Burning Mouth Syndrome/therapy , Burning Mouth Syndrome/etiology , Burning Mouth Syndrome/epidemiology , Prevalence
3.
Neurologia ; 32(4): 219-223, 2017 May.
Article in English, Spanish | MEDLINE | ID: mdl-26778734

ABSTRACT

INTRODUCTION: Burning mouth syndrome is defined as scorching sensation in the mouth in the absence of any local lesions or systemic disease that would explain that complaint. The condition responds poorly to commonly used treatments and it may become very disabling. METHODS: We prospectively analysed the clinical and demographic characteristics and response to treatment in 6 cases of burning mouth syndrome, diagnosed at 2 tertiary hospital headache units. RESULTS: Six female patients between the ages of 34 and 82 years reported symptoms compatible with burning mouth syndrome. In 5 of them, burning worsened at the end of the day; 4 reported symptom relief with tongue movements. Neurological examinations and laboratory findings were normal in all patients and their dental examinations revealed no buccal lesions. Each patient had previously received conventional treatments without amelioration. Pramipexol was initiated in doses between 0.36mg and 1.05mg per day, resulting in clear improvement of symptoms in all cases, a situation which continues after a 4-year follow up period. CONCLUSIONS: Burning mouth syndrome is a condition of unknown aetiology that shares certain clinical patterns and treatment responses with restless leg syndrome. Dopamine agonists should be regarded as first line treatment for this entity.


Subject(s)
Benzothiazoles/therapeutic use , Burning Mouth Syndrome/drug therapy , Burning Mouth Syndrome/physiopathology , Dopamine Agonists/therapeutic use , Adult , Aged , Aged, 80 and over , Burning Mouth Syndrome/diagnosis , Burning Mouth Syndrome/therapy , Female , Humans , Middle Aged , Pramipexole
4.
World J Gastroenterol ; 19(5): 665-72, 2013 Feb 07.
Article in English | MEDLINE | ID: mdl-23429751

ABSTRACT

Burning mouth syndrome is a debilitating medical condition affecting nearly 1.3 million of Americans. Its common features include a burning painful sensation in the mouth, often associated with dysgeusia and xerostomia, despite normal salivation. Classically, symptoms are better in the morning, worsen during the day and typically subside at night. Its etiology is largely multifactorial, and associated medical conditions may include gastrointestinal, urogenital, psychiatric, neurologic and metabolic disorders, as well as drug reactions. BMS has clear predisposition to peri-/post menopausal females. Its pathophysiology has not been fully elucidated and involves peripheral and central neuropathic pathways. Clinical diagnosis relies on careful history taking, physical examination and laboratory analysis. Treatment is often tedious and is aimed at correction of underlying medical conditions, supportive therapy, and behavioral feedback. Drug therapy with alpha lipoic acid, clonazepam, capsaicin, and antidepressants may provide symptom relief. Psychotherapy may be helpful. Short term follow up data is promising, however, long term prognosis with treatment is lacking. BMS remains an important medical condition which often places a recognizable burden on the patient and health care system and requires appropriate recognition and treatment.


Subject(s)
Burning Mouth Syndrome , Burning Mouth Syndrome/diagnosis , Burning Mouth Syndrome/epidemiology , Burning Mouth Syndrome/physiopathology , Humans , Pain Threshold , Predictive Value of Tests , Prognosis , Risk Factors
5.
Article in Spanish | LILACS | ID: lil-706214

ABSTRACT

El síndrome de Boca Ardiente (SBA) se caracteriza por ardor, picor, escozor y dolor bucal sin causa orgánica que lo justifique. La boca ardiente aún es un desafío en el campo de la medicina. Su etiología es desconocida, a pesar de que diversos estudios indican que intervienen una serie de factores locales, sistémicos y psicológicos que se consideran como posibles agentes causales. La saliva puede desempeñar un papel importante en la sintomatología del ardor bucal, presenta propiedades físicas y químicas (reológicas) que determinan funciones imprescindibles para el equilibrio de la cavidad bucal. En pacientes con boca ardiente hay cambios en la composición y tasa del flujo salival relacionados con boca seca, viscosidad, ardor bucal, humedad entre otros. En esta revisión se trata de actualizar varios aspectos que relacionan las distintas causas del síndrome de boca ardiente con la saliva y sus alteraciones como uno de los factores más importantes en la etiología del ardor bucal. Estudios recientes sugieren que el ácido alfa lipoico combinado con gabapentina es un tratamiento efectivo para este síndrome


Burning mouth syndrome is characterized by burning, smarting and oral pain without any organic cause justifying it. Burning mouth is still a challenge in medical field. It has an unknown aetiology; despite many studies indicate the involvement of local, systemic and psychological factors that can be considered possible causal agents. Saliva can perform an important role in oral smarting symptomatology, shows physico-chemical properties (rheological) determining vital functions for oral cavity equilibrium. There are changes in composition and salivary flow rate of burning mouth patients, related with dry mouth, viscosity, oral smarting, and humidity, among others. This review pretends to update many aspects that relate different causes of burning mouth syndrome with saliva and its alterations as one of the most important factors in the aetiology of oral smarting. Recent studies suggest that alpha lipoic acid combined with gabapentin is an effective treatment for this syndrome


Subject(s)
Female , Glossalgia/etiology , Saliva/chemistry , Burning Mouth Syndrome/etiology , Mouth Diseases
6.
Int. j. odontostomatol. (Print) ; 5(1): 23-27, abr. 2011.
Article in English | LILACS | ID: lil-594273

ABSTRACT

El síndrome de boca urente (SBU) es una condición enigmática porque la intensidad de los síntomas rara vez se corresponde con los signos clínicos de la enfermedad. Los síntomas incluyen ardor bucal, boca seca, dolor, cambios en los hábitos alimenticios, graves síntomas de la menopausia, y problemas no específicos de salud, entre otros. SBU es más frecuente en las mujeres posmenopáusicas con relación mujer/hombre de 7:1. La etiología del SBU es multifactorial, como los cambios hormonales (menopausia), las carencias nutricionales y alteraciones del gusto por nombrar algunos. SBU es un reto con respecto al diagnóstico y al manejo. El presente artículo analiza algunos de los acuerdos recientes de la etiopatogenia de SBU, así como el papel de la gestión farmacoterapeutica en este trastorno.


Burning mouth syndrome (BMS) is an enigmatic condition because the intensity of symptoms rarely corresponds to the clinical signs of the disease. Symptoms include oral burning, dry mouth, pain, changes in eating habits, severe menopausal symptoms, and non specific health problems etc. BMS is most prevalent in postmenopausal women with female: male ratio of 7:1. The etiology of BMS is multifactorial such as hormonal changes (menopause), nutritional deficiencies and taste disturbances to name a few. BMS is a challenge to diagnose and manage. The present article discusses some of the recent understanding of etiopathogenesis of BMS as well as the role of pharmacotherapeutic management in this disorder.


Subject(s)
Humans , Burning Mouth Syndrome/epidemiology , Burning Mouth Syndrome/etiology , Burning Mouth Syndrome/therapy , Glossalgia
SELECTION OF CITATIONS
SEARCH DETAIL
...